SOTERA HEALTH COMPANY
Ownership & governance
Executives 5Directors 10Avg age 58Avg tenure 4.7y
AS
Alton Shader
Chief Executive Officer
Age 52Since 2026-05-25Profile →
+14
Executives5
Board of directors10
MP
Michael Petras→
Chairman
Age 58Since 2020-09-30
SC
Sean Cunningham→
Director/Board Member
Age 50Since 2020-09-30
AK
Ann Klee→
Director/Board Member
Age 64Since 2020-04-30
JN
James Neary→
Director/Board Member
Age 61Since 2020-09-30
RC
Ruoxi Chen→
Director/Board Member
Age 42Since 2020-10-31
VP
Vincent Petrella→
Director/Board Member
Age 65Since 2020-10-31
DW
David Wheadon→
Director/Board Member
Age 68Since 2021-04-30
KF
Karen Flynn→
Director/Board Member
Age 63Since 2023-11-12
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Darsana Capital Partners LP | 9.117 % | 26,000,000 |
| Sessa Capital IM LP | 8.083 % | 23,050,000 |
| Sculptor Capital LP | 7.616 % | 21,717,728 |
| BlackRock Advisors LLC | 7.006 % | 19,978,806 |
| Sachem Head Capital Management LP | 5.456 % | 15,560,000 |
Catalog · 2026-07-09
Registry officers15
| Name | Role | Since | Shares |
|---|---|---|---|
| Alton Shader | Chief Executive Officer | 2026-05-25 | - |
| Jon Lyons | Director of Finance/CFO | 2023-06-25 | - |
| Michael Petras | Chairman | 2020-09-30 | - |
| Robert Hauzie | Chief Tech/Sci/R&D Officer | 2018-12-31 | - |
| Ann Klee | Director/Board Member | 2020-04-30 | - |
| Christopher Simon | Director/Board Member | 2024-07-31 | - |
| David Wheadon | Director/Board Member | 2021-04-30 | - |
| James Neary | Director/Board Member | 2020-09-30 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 22.61Range 17–25Analysts 9
17Mean 22.6125
- Strong buy 3
- Buy 5
- Hold 1
- Strong sell 1
Broker actions40 of 77
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| JP Morgan | Downgrade | Underweight | 17 | 2026-10-14 |
| Citigroup | Maintained | Buy | 25 | 2026-08-07 |
| Barclays | Maintained | Overweight | 22 | 2026-08-07 |
| Piper Sandler | Reiterated | Overweight | 25 | 2026-08-07 |
| JP Morgan | Maintained | Neutral | 18 | 2026-08-07 |
| Barclays | Maintained | Overweight | 19 | 2026-06-24 |
| Goldman Sachs | Initiated | Buy | 20 | 2026-06-05 |
| Piper Sandler | Reiterated | Overweight | 22 | 2026-05-06 |
| Barclays | Maintained | Overweight | 18 | 2026-04-14 |
| Citigroup | Maintained | Buy | 23 | 2026-02-24 |
| Piper Sandler | Upgrade | Overweight | 24 | 2026-01-09 |
| William Blair | Initiated | Outperform | — | 2025-12-18 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.